Table 2.
Study | Total | Cases | Controls | Arrays | Batches | Country |
---|---|---|---|---|---|---|
GenoTPA [9] | 157 | 36 | 121 | HumanOmni1-Quad BeadChip (Illumina) | 1 | Spain |
BASICMAR | 91 | 8 | 83 | Human Omni Quad 5M (Illumina) | 1 | Spain |
LSGS | 45 | 8 | 37 | Human Omni Quad 5M (Illumina) | 1 | Belgium |
HELSINKI2000 | 164 | 12 | 152 | HumanCoreExome (Illumina) | 1 | Finland |
GENISIS [15] | 70 | 2 | 68 | HumanCoreExome (Illumina) | 1 | Finland |
53 | 4 | 49 | HumanCoreExome (Illumina) | 1 | Poland | |
484 | 42 | 403 | HumanCoreExome (Illumina) | 1 | Spain | |
Total | 1064 | 112 | 913 | 7 | Spain |
GenoTPA: Genetic Study in Ischemic Stroke Patients treated with recombinant tissue plasminogen activator (r-tPA); BASICMAR: BAse de Datos de ICtus del hospital del MAR; LSGS: Leuven Stroke Genetics Study; HELSINKI2000: Helsinki 2000 Ischemic Stroke Genetics Study; and Genetics of Early Neurological Instability After Ischemic Stroke studies.